January 29, 2019

Hepatitis C Prevalent in Less Than 1% of US Population

Novel epidemiological approach accounting for persons with undiagnosed HCV shows half of cases in US are in 9 states, including 5 in Appalachia. Epidemiologists found a […]
January 24, 2019

Mapping Core Hepatitis C Areas Improves Targeted Treatment

Mapping techniques for tracking sexually transmitted bacterial disease can also identify core areas of HCV infection to guide treatment interventions. Mapping techniques for identifying ‘core areas’ […]
January 17, 2019

Hepatitis C Genotype 3 Treated with Shortened Glecapravir/Pibrentasvir

Analysis of data from phase 2 and 3 trials supports an HCV genotype 3 indication for glecaprevir/pibrentasvir, and confirms its efficacy over 8 weeks. An integrated […]
January 10, 2019

Screening For Hepatitis C Virus Lags At Drug Treatment Clinics

As the number of people who inject drugs and share needles has soared, the rate of infection with hep C has climbed, too. Yet many drug […]
January 8, 2019

What’s the Difference Between Hepatitis A, B, and C?

Did you know there are different types of hepatitis? The three most common are A, B, and C, each named for the specific virus that causes […]
January 3, 2019

 Hepatitis C Screening And New Treatments Allow Baby Boomers To Escape “The Kiss of Death”

Finding out you have stage 3 hepatitis C (HCV) might not be most people’s idea of luck, but Ron Shean feels fortunate. Despite the damage to […]
December 27, 2018

Hepatitis C Reinfection Rates Greater in Drug Users Despite DAAs

  Investigators also found that opiate agonist therapy could have a positive effect in limiting reinfection rates after patients achieve SVR. A population-based study of 1.7 […]